. Indeed gelsolin, a G-actin sequestering and F-actin capping ABP, is released from membrane fractions when PLC is activated (Chen et al., 1996) . However, the direct visualization in living cells of the PIP 2 hydrolysis and the subsequent translocation from the PM and activation of ABPs is generally lacking. Here, we have tested this hypothesis in living cells for cofi lin because the EGF-induced activation of cofi lin is PLC dependent in breast carcinoma cells, and because cofi lin has been proposed to bind to PIP 2 in vitro.
Introduction
EGF is an important chemoattractant in hematogenous metastasis of mammary tumors Kedrin et al., 2007) . Upon EGF stimulation, mammary carcinoma cells start to form cellular protrusions critical for chemotaxis, such as lamellipodia and invadopodia. In carcinoma cells these changes in morphology are driven by restructuring of the actin cytoskeletal network by several actin-binding proteins (ABPs; Condeelis et al., 2005) . Cofi lin, an actin-severing protein, is important for the initial regulation of actin polymerization during EGF stimulation . Active cofi lin binds to and severs F-actin, thereby increasing the number of free barbed ends . In addition, barbed ends may also be increased by the intrinsic nucleation activity of cofi lin (Andrianantoandro and Pollard, 2006) . The actin polymerization activity of cofi lin is consistent with observations that the local activation of cofi lin causes local actin polymerization and cellular protrusions in vivo Mouneimne et al., 2006) , which places cofi lin as a key protein in chemotaxis of metastatic cancer cells. Indeed, the invasion signature of breast carcinoma cells showed that cofi lin is an important contributor to the metastatic phenotype , and recent fi ndings show that the activity status of cofi lin is directly related to invasion, intravasation, and metastasis of mammary tumors .
In EGF-stimulated mammary carcinoma cells, the increase in cofi lin-dependent barbed ends occurs in two transients: one at 1 min, and a late one at 3 min . The fi rst barbed end transient depends on PLC , but not on PI3K or cofi lin-dephosphorylation activity Song et al., 2006) , and is required for directional sensing during chemotaxis . However, it is not clear how PLC regulates cofi lin activity. PLC cleaves the plasma membrane (PM) phospholipid PIP 2 into DAG and IP 3 . Structural and in vitro-binding studies suggest that PIP 2 can regulate ABPs such as cofi lin. For example, structural studies showed that the putative PIP 2 -binding sites of many ABPs are overlapping with the sites that are important for F-actin binding, and therefore lipid binding would prevent actin binding (Yonezawa et al., 1990; Ojala et al., 2001; Yin and Janmey, 2003; Gorbatyuk et al., 2006) . In vitro-binding studies showed that the activity of many ABPs is inhibited by PIP 2 -containing lipid micelles. Therefore, it has been hypothesized that ABPs bind to and are inhibited by PIP 2 in the PM, and upon PLC-mediated PIP 2 reduction, the ABPs get released and activated (Goldschmidt-Clermont et al., 1991 , 1992 Janmey and Lindberg, 2004; Di Paolo and De Camilli, 2006; Janetopoulos and Devreotes, 2006; Logan and amellipodial protrusion and directional migration of carcinoma cells towards chemoattractants, such as epidermal growth factor (EGF), depend upon the spatial and temporal regulation of actin cytoskeleton by actinbinding proteins (ABPs). It is generally hypothesized that the activity of many ABPs are temporally and spatially regulated by PIP 2 ; however, this is mainly based on in vitrobinding and structural studies, and generally in vivo evidence is lacking. Here, we provide the fi rst in vivo data that directly visualize the spatial and temporal regulation of cofi lin by PIP 2 in living cells. We show that EGF induces a rapid loss of PIP 2 through PLC activity, resulting in a release and activation of a membrane-bound pool of cofi lin. Upon release, we fi nd that cofi lin binds to and severs F-actin, which is coincident with actin polymerization and lamellipod formation. Moreover, our data provide evidence for how PLC is involved in the formation of protrusions in breast carcinoma cells during chemotaxis and metastasis towards EGF.
Results

EGF stimulates PLC-dependent PIP 2 reduction in MTLn3 cells
To test whether cofi lin activity can be regulated by PIP 2 , we fi rst studied whether changes in the PIP 2 level can be induced upon EGF stimulation in the rat MTLn3 carcinoma cell line. We have chosen this cell type for study because cofi lin-induced formation of barbed ends, cell protrusion, and chemotaxis is PLC dependent , and the metastatic potential of mammary tumors resulting from the growth of these cells is dependent on the activity status of cofi lin . To follow rapid changes in PIP 2 levels in vivo, we used a FRET-based PIP 2 assay that provides high temporal resolution (van der Wal et al., 2001; van Rheenen and Jalink, 2002;  for details see Materials and methods and Fig. S1 , available at http://www.jcb.org/cgi/ content/full/jcb.200706206/DC1). A fast and signifi cant drop in PIP 2 -FRET was observed upon EGF stimulation in MTLn3 (14 ± 5%) and EGFR-overexpressing MTLn3 cells (22 ± 2.5%), accompanied by an increase in cell protrusion activity measured as an increase in cell area (Fig. 1 A) . This observation was confirmed by immunofluorescence of fixed MTLn3 cells using PIP 2 -specifi c antibodies (Fig. S2 ) before and 1 min after EGF stimulation ( Fig. 1 A, middle) . In resting cells, the antibody staining of PIP 2 at the PM was higher compared with stimulated cells, indicating a decrease of this lipid ( Fig. 1 A, right) . Analysis of the fl uorescent labeling intensities suggests a drop in the PIP 2 levels of 40 to 60%. Biochemical analysis of low-density membrane fractions showed similar decreases in PIP 2 after EGF stimulation (see below). These data suggest that the PLC-induced increase in cell area may indeed be initiated by PIP 2 hydrolysis. If so, then inhibition of PLC should block PIP 2 hydrolysis and subsequently the cell area increase. Mouneimne et al. (2004) observed a block in the cell protrusion activity in the fi rst 3 min after EGF exposure in cells treated with the PLC inhibitor U73122, but they observed normal protrusion in cells treated with U73343, an inactive form of this drug. In line with this, we found that EGF-stimulated PIP 2 hydrolysis is inhibited by U73122, but not by U73343 (Fig. 1, B and C) , suggesting that the EGFinduced increase in protrusion (cell area) is dependent on PLC through reduction in PIP 2 . We have also reduced the level of PIP 2 by an EGF-independent mechanism. In a recent report, it was noted that PIP 2 levels can be reduced by cholesterol extraction with MβCD (Kwik et al., 2003) . We observed the same phenomenon in our cell type. Both FRET level (33 ± 5%) and antibody staining were lower after MβCD treatment, suggesting decreased PIP 2 levels (Fig. 1 D) . Moreover, MβCD treatment resulted in an increase in cell area (Fig. 2 A) . Although MβCD may have many side effects and is therefore a blunt tool to reduce PIP 2 levels, the observed decrease in PIP 2 and the increase in cell area are in line with the idea that PIP 2 reduction is inducing formation of cellular protrusions.
Co-localization between cofi lin and PIP 2 is diminished upon PLC-dependent PIP 2 reduction
Our model predicts that a fraction of cofi lin is associated with PIP 2 in the PM and is inactive, and that upon PIP 2 reduction by EGF stimulation, this fraction of cofi lin leaves the PM and becomes active. To test this, we studied the spatial distribution of cofi lin before and after PIP 2 reduction. In unstimulated cells, a fraction of cofi lin is localized at the periphery of the cell, and is closely associated with the PM (Fig. 2 A, left) . We hypothesize that this is the nonphosphorylated fraction of cofi lin that is kept inactive by PIP 2 . Upon either EGF stimulation or MβCD treatment, cells form cellular protrusions resulting in the PLCdependent increase in cell area (Fig. 2 A; . Cofi lin is locally released from its peripheral enrichment and translocates to the leading edge of the newly formed lamellipodia ( Fig. 2 A, right) . We hypothesize that the cofilin in the actin-rich leading edge of lamellipodia is not bound to the membrane PIP 2 and therefore active. To test our hypothesis, we analyzed the immunostaining of PIP 2 and cofi lin at these two regions of the cell. First we compared the colocalization of PIP 2 with the phosphorylated-and nonphosphorylated form of cofi lin. We predict that the spatial relationship between PIP 2 and membrane-bound cofi lin should be greater than PIP 2 and nonmembrane-bound cofi lin. The spatial relationship was analyzed with scatterplots and Pearson's correlation coeffi cient analysis of immunofl uorescence images, and they indeed showed that PIP 2 has a higher spatial relationship with the membrane-bound and nonphosphorylated form of cofi lin than with the cytosolic and phosphorylated form of cofi lin (Fig. 2, B and C) . This suggests that the membrane-bound fraction of cofi lin is a nonphosphorylated form of cofi lin. To test whether this fraction gets released at lower PIP 2 levels, cells were stimulated with EGF or treated with MβCD (Fig. 1) . Changes in PIP 2 staining intensity do not infl uence the outcome because Pearson's correlation coeffi cient is insensitive to relative changes in the intensities of the two images (Fig. S3 , available at http://www.jcb.org/cgi/content/ full/jcb.200706206/DC1). As predicted by our hypothesis that cofi lin is associated with PIP 2 and released as PIP 2 levels fall, the Pearson's correlation coeffi cient indeed drops (Fig. 2 B) and the scatterplot shows less spatial correlation (Fig. 2 C) , suggesting that PIP 2 and cofi lin become spatially segregated after stimulation with EGF or treatment with MβCD. Biochemical analysis of membrane fractions by dot blots to detect PIP 2 and Western blot to detect cofi lin confi rmed that cofi lin is lost from the PM in association with a drop in the amount of PIP 2 after EGF-stimulation or MβCD treatment (Fig. 2, D-F) .
If a PLC-dependent drop in the PIP 2 level is responsible for the translocation of cofi lin from the PM and the subsequent protrusion of the cell, then inhibition of PLC should prevent cofi lin translocation from the PM. In cells treated with U73122, but not cells treated with the control drug U73343, EGF neither induced a drop in the membrane-associated PIP 2 (Fig. 2 E) nor a decrease in the PIP 2 labeling levels ( Fig. 1 C) . Interestingly, the inhibition of PIP 2 hydrolysis was associated with retention of membrane-bound cofi lin (Fig. 2 F) and the inhibition of the disruption of colocalization between cofi lin and PIP 2 (Fig. 2 , B and C). These data strongly suggest that cofi lin is membraneassociated and that upon EGF-mediated PIP 2 hydrolysis cofi lin gets released from the PM.
Cofi lin leaves the PM upon PLC-dependent PIP 2 reduction in living cells
To follow the translocation of cofi lin in living cells, we expressed a chimera of GFP and cofi lin in MTLn3 cells. GFP-cofi lin is recognized by GFP and cofi lin antibodies and the localization by GFP is similar to that found by antibody staining (Fig. 3,  A and B) . Translocation of GFP-cofi lin from the PM was measured by FRET between GFP-cofi lin and a membrane-targeted mCherry (mCherry-CAAX) (Fig. 3 C) . FRET (as measured by sensitized emission [sens]) was only observed at the PM (Fig. 3 D; for control cells see Fig. S4 A, available at http://www.jcb.org/ cgi/content/full/jcb.200706206/DC1) because mCherry-CAAX labeled exclusively the PM and FRET only occurs for molecules in close proximity (<10 nm) (Fig. 3 C) . FRET (sens) values may vary between cells due to (1) variations in expression levels of the fl uorescent proteins (van Rheenen et al., 2005) , and (2) different excitation and detection settings (e.g., PMT settings) (van Rheenen et al., 2004) . However, we compared FRET (sens) values in the same cells before and after stimulation, thus the concentration of the probes or the detection sensitivity did not change during the experiment and FRET changes can be observed as relative changes to the initial FRET (sens) value. Translocation of cofi lin from the PM led to a loss of FRET, and indeed, a rapid decrease in cofi lin FRET (sens) was observed upon EGF stimulation and MβCD treatment ( Fig. S4 B) , which was accompanied by an area increase resulting from EGF-stimulated protrusion (Fig. 3 E) . GFP-cofi lin translocation is PLC dependent because FRET (sens) decreases were not observed in cells treated with U73122 ( Fig. 3 D and Fig. S4 B) . To control for photobleaching (<5%) or the apparent redistribution of the probes during EGF-induced changes in cell shape, we divided the sensitized emission by the total amount of GFP or mCherry to obtain apparent donor (E d ) and acceptor (E a ) FRET effi ciency. This concentration-independent FRET analysis confi rmed EGF-induced FRET changes (Fig. S4 B) excluding any effects of bleaching and redistribution of the probe. To test this in more detail, we measured FRET (sens) between mCherry-CAAX and a GFP that was continuously tagged to the PM (GFP-CAAX) (Fig. S4 C) . As expected, EGF stimulation did not result in lower FRET values. These data, together with the FRET effi ciency analysis, exclude that FRET (sens) changes observed in Fig. 3 , D and E, are a result of (1) changes in mCherry-CAAX, (2) changes in cells shape, and (3) photobleaching. Images were collected before and 1 min after EGF stimulation. The spatial relationship between PIP 2 and cofi lin was analyzed with Pearson's correlation coeffi cient analysis (all conditions n > 25). (C) Shown are the merge and the scatterplot images of the cofi lin and PIP 2 channels. Scatterplots are from the fi rst 1 μm from the cell edge and were obtained from images that were smoothed ones using ImageJ. The loss in PIP 2 signal was compensated by longer exposure times. Note that the higher the spatial relationship between PIP 2 and cofi lin, the more pixels in the scatterplot align along the diagonal (n = 8).
(D) The amount of cofi lin in the low-density membrane fraction was analyzed by Western blot in cells stimulated with EGF or treated with MβCD. Note that in contrast to cellular cofi lin (Cell Cof.), pure cofi lin added to the isolation procedure does not localize in these gradient fractions (three independent experiments). The amount of PIP 2 in low-density membrane fractions of cells treated with the PLC-inhibitor U73122 or the nonactive form U73343 was analyzed by dot blot (E) and the amount of cofi lin in the same fraction was determined by Western blot (F) (three independent experiments). Values were statistically tested by t test. *, P < 0.05; **, P < 0.01; error bars represent SEM.
To test whether GFP-cofi lin translocation from the PM represents the endogenous cofi lin translocation, we measured FRET between immunostained endogenous cofi lin (Alexa 488) and mCherry-CAAX by acceptor photobleaching experiments. As illustrated in Fig. S4 , D and E, these experiments indeed suggest that the in vivo-observed translocation of GFP-cofi lin upon EGF represents the translocation of endogenous cofi lin from the PM, and that this translocation is dependent of PLC-mediated PIP 2 hydrolysis. Collectively, we conclude that cofi lin leaves the PM upon PLC-mediated PIP 2 reduction in living cells.
Cofi lin leaves the PM upon PLC-independent PIP 2 reduction
Collectively, our data suggest that the translocation of cofi lin from the PM is mediated by PLC-dependent reduction in PIP 2 . If so, then the reduction of PIP 2 by other means should also cause cofi lin to leave the PM. Rapid loss of PIP 2 -independent PLC can be initiated by a rapamycin-induced recruitment of a phosphoinositide 5-phosphatase (5-ptase) enzyme domain to the PM (Fig. 4 A; Fig. S5 , available at http://www.jcb.org/cgi/ content/full/jcb.200706206/DC1). This translocation is mediated by the heterodimerization of the FRB domain at the PM and the FKBP12-tagged 5-ptase domain upon rapamycin exposure (Heo et al., 2006; Varnai et al., 2006) . The 5-ptase domain dephosphorylates PIP 2 into PIP, leading to the loss of PIP 2 at the PM (Fig. 4 A) . In line with our PLC data, rapamycin also induced the translocation of cofi lin from the PM (Fig. 4 B) , confirming that this translocation is mediated by a loss in PIP 2 . Moreover, upon rapamycin exposure, we observed the formation of membrane protrusions, suggesting an activation of cofi lin (Fig. 4 C; Video 1, available at http://www.jcb.org/cgi/ content/ full/jcb.200706206/DC1). As expected, rapamycin-induced membrane protrusions are not inhibited by the PLC inhibitor U73122 (Fig. 4 C) .
From all this, we conclude that cofi lin translocates from the PM upon rapamycin-induced PIP 2 reduction, and that this leads to the formation of membrane protrusions.
Cofi lin released from the PM is active
Our model predicts that the translocation of the spatially confi ned and membrane-associated cofi lin (Fig. 2 A, the xz projection) will lead to a local increase in activity. Active cofi lin binds to and severs F-actin . To test whether cofi lin activity increases upon PLC-mediated PIP 2 reduction, we measured cofi lin binding to F-actin by FRET. MTLn3 cells were fi xed using a method that retains F-actin but loses G-actin and immunostained for endogenous cofi lin (donor: Alexa 488) and F-actin (acceptor: rhodamine), and FRET was measured by acceptor photobleaching experiments. If cofi lin is membrane bound, the distance between cofi lin and F-actin is large, resulting in low FRET values. If cofi lin is bound to F-actin, these molecules are in close proximity and FRET will be high in a relatively non-diffusible location. Cofi lin/actin FRET increased upon EGF stimulation or MβCD-treatment, indicating that cofi lin binds to actin fi laments within 60 s after EGF stimulation (Fig. 5 A) . Interestingly, cofi lin-actin fi lament binding is reduced if PLC is inhibited, showing that the cofi lin that binds to F-actin originates from the PM (Fig. 5 A) . Strikingly, localized application of EGF by a micropipette resulted in a localized increase in FRET, where FRET values were two times Varnai et al. [2006] ). PIP 2 levels were followed by YFP-PH(PLCδ1) (A), and the cofi lin membrane localization was followed by GFP-cofi lin (B). Below the images, the intensity profi les of FRB, PH, and 5-ptase fl uoresence through the cell are shown. The blue lines represent pre and the red lines represent post-rapamycin (n > 15). Bars, 5 μm. (C) The formation of lamellipodia upon rapamycin (t = 0) addition was followed by confocal microscopy (see also Video 1, available at http://www.jcb .org/cgi/content/full/jcb.200706206/DC1). Shown are the images of PM-targeted CFP-FRB domains, before (t = 0) or 21 s (t = 21) after rapamycin addition. The right image represent a merge of binary threshold images (ImageJ) of image t = 0 and t = 21. Yellow represents no change, red represents increase lamellipod formation. The bottom images show the kymograph of the formation of the lamellipod, and the area of the cell that was used for the kymograph. From the kymographs, the size of the lamellipod was measured and plotted against time (right panel) for nonstimulated cells (control, red dashed line), rapamycin-stimulated cells (rapa, red line), and for cells that were treated with U73122 and stimulated with rapamycin (U73122 + rapa, blue line) and for cells that were treated with U73122 only (U73122 control, blue dashed line). n = 12; error bars represent SEM.
higher at the front of the cell close to the pipette than at the opposite side of the cell (Fig. 5 B) . This strongly suggests that localized EGF application results in a local translocation of cofi lin from the PM to F-actin.
Cofi lin switches from PM binding to F-actin binding
To investigate the switch between PM and actin fi lament binding by cofi lin after EGF stimulation, we performed fl uorescence loss in photobleaching (FLIP) experiments. GFP-cofi lin stains the periphery and cytosol. With an intense laser, a region in the cytosol was bleached, and we measured the fl uorescence intensity at the periphery (Per), and in the cytosol (Cyt) over time (Fig. 6 A) . Because cofi lin molecules localized at the periphery are retained at the PM or on actin fi laments, those molecules will be bleached less effi ciently compared with the free diffusible cytosolic cofi lin molecules, leading to an increase in the ratio of Per/Cyt staining (Fig. 6 A, right graph) . The residence time of cofi lin on actin fi laments or the PM determines how fast the Per/ Cyt ratio returns to baseline. If the actin fi lament and PM residence times are different, a change in the ratio of PM/actin binding will lead to a change in the overall residence time of cofi lin at the periphery, and thus also the recovery time. Photobleaching during image acquisition or fl uctuations in the laser power will equally infl uence the fl uorescence loss of the periphery and the fl uorescence increase in the cytosol, and therefore do not infl uence the outcome. To test the dynamic range of our FLIP experiment, a freely diffusible GFP and a PM-tagged GFP (coexpressed with free diffusible GFP as cytosolic marker) were tested. As can be seen in Fig. 6 B, free diffusible GFP recovers very fast, whereas the recovery of PM-tagged GFP recovers very slowly. To test whether cell shape changes infl uence the recovery rate caused by a change in PM background bleaching, the cells were stimulated with EGF. As shown in Fig. 6 B, this does not infl uence the recovery of PM-tagged GFP, excluding cell shape effects on recovery rates. The same experiments were performed for GFPcofi lin. In unstimulated cells, GFP-cofi lin recovers rapidly, whereas in EGF-stimulated cells, the recovery is much slower. Inhibition of PLC by U73122 generates recovery rates for GFP-cofi lin equal to the unstimulated rate (Fig. 6 C) . We fi tted the cofi lin data with two component exponential decays representing the PM and actin binding, with a fast component of 3.7 and a slow component of 26 s. Unstimulated cells contain predominately the fast fraction (85%), whereas the stimulated cells contain predominately the slow fraction (62%) (Fig. 6 D) . Because FRET experiments of cofilin-PM and cofilin-actin filaments showed that cofilin in unstimulated cells is predominately bound to the PM, and in EGF-stimulated cells predominately bound to F-actin, it is very 488 ) and F-actin (acceptor; rhodamine). Using a high laser power, a region was bleached in the acceptor fl uorescence (white square box). The increase in the donor fl uorescence was measured and FRET was calculated for un-treated, U73122-treated, or MβCD-treated cells (right panel; for all n > 15). (B) FRET was measured in a cell that was stimulated by local application of EGF using a pipette (asterisk). In the graph we plotted the normalized FRET values at the side of the cell close to the pipette (front) and the opposite side of the cell (back) (n = 5). Values were statistically tested by t test. *, P < 0.05; **, P < 0.01; error bars represent SEM.
likely that the fast component is membrane-bound cofi lin, while the slow component is the F-actin-bound cofi lin. This means that in unstimulated cells, 85% of cofi lin molecules located at the periphery is PM bound, which goes down to 38% upon EGF stimulation, except in PLC-inhibited cells (Fig. 6 D) . The actin fraction is 15% in unstimulated cells, which increases to 62% after EGF stimulation, which is blocked when PLC is inhibited (Fig. 6 D) . Thus, our FLIP data are consistent with the interpretation that upon EGF stimulation, cofi lin translocates from the PM to underlying F-actin.
To investigate the activation state of cofi lin during the time it is being released from the PM, we measured activity of cofi lin in cell lysates prepared from cells either before or after EGF stimulation, and then using a cofi lin-severing assay to measure cofi lin activity in the cell lysate. Indeed, PIP 2 reduction either induced by EGF-stimulation or MβCD treatment (Fig. 1) leads to an increase in the severing activity of cofi lin (Fig. 6 E) . Importantly, the PLC inhibitor U13122 potently inhibits the EGF-induced increase of cofi lin-severing activity (Fig. 6 E) , showing that this increased severing activity is dependent on PIP 2 reduction and cofi lin translocation from the PM to F-actin.
Discussion
PLC activity is required for EGF-induced actin polymerization and cell motility of mammary carcinoma cells (Chen et al., 1994; Mouneimne et al., 2004 Mouneimne et al., , 2006 ; however, the molecular basis of how PLC regulates actin dynamics and motility is not well established. The data presented in this manuscript explain how PLC affects the activity of a PM-associated fraction of The membrane and actin binding of GFP-cofi lin was followed by FLIP experiments on the confocal microscope at 25°C. At time 0, the cytosolic GFP-cofi lin was bleached briefl y (bleach region indicated in yellow) and the fl uorescence at the cell periphery (Per in blue) and the cytosol (Cyt in red) were followed over time (middle graph). Upon bleaching, the Per/Cyt ratio increases, and because of exchange of molecules in the Cyt and Per, the ratio decreases to baseline. To normalize for bleach effi ciencies, the initial ratio was set to 0 and the fi rst point after bleaching was set to 1. cofi lin, resulting in changes in actin polymerization and protrusion. The invasion signature of breast carcinoma cells has shown that cofi lin is an important contributor to the metastatic phenotype , and recent fi ndings show that the activity status of cofi lin is directly related to the invasion, intravasation, and metastasis of mammary tumors Wang et al., 2006 Wang et al., , 2007 . The initial cofi lin activation after EGF stimulation in metastatic tumor cells is independent of PI3K and cofi lin dephosphorylation Song et al., 2006) . Here, we provide evidence for the requirement of PLC during the initial activation of cofi lin and provide the mechanism by which this occurs during EGF-mediated protrusion formation and metastasis. It is important to note that the mechanism described in this paper applies to metastatic amoeboid tumor cells in which migration is PLC dependent and cofi lin dependent . In this cell type, the initial activation of cofi lin upon EGF stimulation is uncoupled from its phosphorylation status, and therefore the activation of cofi lin is highly dependent on PLC. However, it has been shown recently in less metastatic mesenchymal-type tumor cells that the phenotype of cofi lin suppression is different, suggesting that cofi lin may be regulated by alternate pathways which may be cell-type dependent (Sidani et al., 2007; Wang et al., 2007) . Therefore, in some cell types, the activation may be more dependent on the dephosphorylation of cofi lin by phosphatase such as slingshot, while the PLC-mediated pathway plays a less prominent role (Nishita et al., 2005; Soosairajah et al., 2005) . This supports the idea that both mechanisms are physiologically important, but the contribution of either of the signaling pathways may differ in different cell types and under various conditions.
In this manuscript, we tested the hypothesis that a pool of cofi lin is associated with and inhibited by PIP 2 in the PM, and that it can be released and activated upon PLC-mediated PIP 2 hydrolysis. Using biochemical, FRET, and FLIP experiments, we identifi ed three cofi lin compartments in the cell-the cytosolic, PM-associated, and F-actin-bound compartments-the latter two at the periphery of the cell. FLIP experiments showed that cofi lin can rapidly cycle between these compartments and that upon EGF stimulation, cofi lin molecules at the PM compartment translocate to the F-actin compartment. These observations suggest the activity cycle shown in Fig. 7 . In unstimulated cells, cofi lin at the cell periphery is mainly localized in the PM compartment. Upon EGF-induced PIP 2 reduction, this pool is released from the PM and translocates to the nearby F-actin compartment. The increase in the number of cofi lin molecules that bind to actin fi laments leads to actin severing, which in turn leads to an increase in free barbed ends and cofilin-G-actin products. The cofilin-G-actin product is not able to bind to F-actin or the PM, and therefore diffuses to the cytosol compartment. Cofi lin is released from the cofi lin-G-actin complex by phosphorylation in order to reenter the PM or F-actin compartments. The result of releasing cofi lin from the PM is an increase in the number of barbed ends in the F-actin compartment followed by the elongation of fi laments by polymerization from the barbed ends of the severed fi laments. The newly polymerized actin fi laments are preferred by the ARP2/3 complex for binding (Ichetovkin et al., 2002) . Each ARP2/3 complex nucleates a new daughter branch from the side of the cofi lin-generated mother fi lament, resulting in a large amplifi cation of actin polymerization resulting from cofi lin activity. This actin polymerization is the driving force for the formation of membrane protrusions.
In line with our model, we observed that rapamycininduced PIP 2 reduction leads to translocation of cofi lin from the membrane with the subsequent formation of membrane protrusions. In contrast to EGF stimulation, the protrusions caused by rapamycin-induced PIP 2 reduction are small and do not persist. This is consistent with recent work showing (1) that EGF-induced lamellipod extension requires both cofi lin and ARP2/3, which cooperate and act synergistically in driving dendritic nucleation and membrane extension (Ichetovkin et al., 2002; DesMarais et al., 2004) ; and (2) that acute loss of PIP 2 induced by rapamycin leads to loss of ARP2/3 subunits from lamellipods (Zoncu et al., 2007) . Contrastingly, EGF stimulation leads to cofi lin activation without negatively affecting ARP2/3 localization . Therefore, in the case of EGF stimulation, cofi lin and ARP2/3 are activated together, resulting in the formation of stable and large protrusions. In the case of rapamycin, the initial cofi lin-induced actin polymerization is not amplifi ed by ARP2/3, leading to the formation of small protrusions with a subsequent collapse. These results suggest that rapamycininduced PIP 2 reduction that leads to depletion of ARP2/3 can lead to lamellipod collapse (Zoncu et al., 2007) , and our results suggest that the extent of collapse can be counteracted by the activation of cofi lin.
As illustrated in Fig. 7 , our data demonstrated that cofi lin molecules at the PM compartment are released and activated by decreases in the PIP 2 level induced by PLC or a 5-ptase. Whether cofi lin at the PM compartment is inactive through direct PIP 2 binding or indirectly through an adaptor molecule cannot be concluded from our data. For example, we cannot exclude the possibility that cofi lin interacts with a protein at the PM, resulting in cooperative PM binding and cofi lin inactivation. Cooperative binding may lead to a higher apparent affi nity for the PM than expected from in vitro-binding affi nities (McLaughlin et al., 2002) and the strong selectivity of PM association for the dephosphorylated form of cofi lin, which is not predicted from structural studies (Gorbatyuk et al., 2006) . A reduction of PIP 2 in the PM may lead to a direct reduction of cofi lin-PIP 2 binding, or in the case of cooperative binding, it may lead to a reduced cofi lin adaptor protein binding or adaptor protein PIP 2 binding. Although we cannot exclude cooperative binding, existing biochemical data point toward direct binding of cofi lin to PIP 2 because cofi lin binds specifi cally to PIP 2 in PIP-strips (unpublished data), and cofi lin activity in vitro is inhibited by micelles containing PIP 2 (Yonezawa et al., 1990 (Yonezawa et al., , 1991 Ojala et al., 2001) . Although the binding mechanisms in both models may differ, the output is the same: PIP 2 reduction leads to the release from the PM and a local activation of cofi lin.
In polarized cells, the activation of cofi lin is restricted toward the chemoattractant source achieved by a local excitation global inhibition (LEGI) mechanism . This LEGI mechanism involves the global phosphorylation of cofi lin in the cytosol compartment by LIMK in response to EGF stimulation in breast carcinoma cells in concert with cofi lin's local activation by PLC at the PM and its translocation to the F-actin compartment (Fig. 7) . The rapid phosphorylation of cofi lin close to the actin compartment acts to sharpen the spatial location of cofi lin activation. Therefore, the local activation of cofi lin by PLC as shown in this study is the key to the initiation of local actin polymerization required for chemotaxis, as postulated previously Song et al., 2006) .
It has been widely hypothesized that the activities of various ABPs such as gelsolin, profi lin, capping protein, and cofi lin are modulated by phospholipid binding (Janmey and Lindberg, 2004; Di Paolo and De Camilli, 2006; Janetopoulos and Devreotes, 2006; Logan and Mandato, 2006) . However, this hypothesis is mainly based on structural and in vitro-binding studies. Here, we provide compelling in vivo evidence demonstrating the activation of an ABP, cofi lin, by varying a phospholipid, PIP 2 . Furthermore, we have demonstrated that the activation of cofi lin by PLC-induced changes in PIP 2 levels causes a translocation of cofi lin from the PM compartment to the F-actin compartment, suggesting a mechanism for how the activities of other PIP 2 -regulated ABPs may be localized in cells.
Materials and methods
Cell culture
MTLn3 (rat mammary adenocarcinoma cell line) cells were maintained, starved as described previously . For light microscopy experiments, MTLn3 cells were plated on glass-bottom dishes (MatTek Corporation) that had been treated with HCl and ethanol and washed with PBS. For PIP 2 FRET experiments, the dishes were coated with poly-Llysine (Sigma-Aldrich) and collagen. Before the experiments, cells were starved in L15 medium (Invitrogen) supplemented with 0.35% BSA for 2.5 to 4 h. A bath application of 5 to 15 nM EGF (Invitrogen) for 1 min or 5 mM methyl-β-cyclodextrin (MβCD) for 2.5 min was used to stimulate the cells.
DNA constructs and transfections
The pNA3 expression vectors with inserts eCFP-PH(PLCδ1), and GFP-CAAX were a gift of K. Jalink (Netherlands Cancer Institute, Amsterdam, The Netherlands). PM-FRB-CFP and mRFP-FKBP-5-ptase domain were a gift of T. Balla (National Institute of Child Health and Human Development, NIH, Bethesda, MD). pEYFP-Mem was from Clonetech Laboratories, Inc. pcDNA3 with the insert of mCherry-CAAX was obtained by replacing GFP of pcDNA3-GFP-CAAX with mCherry using the BamHI and EcoRI restriction sites. GFP-cofi lin was constructed by subcloning the rat cofi lin from peGFP-N1-cofi lin (described in DesMarais et al. [2004] ) into pEGFP-C1 with HindIII. A frame shift was corrected by removing the overhang of SacI by T4 polymerase. Constructs were transfected using Lipofectamine 2000 Figure 7 . Compartments involved in the cofi lin activity cycle. Cofi lin molecules cycle through three compartments in the cell; the cytosol, the actin, and the PM compartments. Cofi lin at the PM compartment initially translocates to the F-actin compartment upon EGF mediated PIP 2 reduction. Cofi lin binds and severs actin fi laments resulting in fi laments with free barbed ends, and cofi lin-G-actin complex. The cofi lin-G-actin complex cannot bind actin or PM, and therefore diffuses to the cytosol compartment. In the cytosol compartment, cofi lin is phosphorylated by LIM-kinase, resulting in the release of cofi lin from the cofi lin-G-actin complex. Upon cofi lin dephosphorylation by SSH, cofi lin can reenter the PM or F-actin compartment, starting a new cycle. The cycling of cofi lin through the three compartments increases free barbed ends, resulting in newly polymerized actin fi laments. The ARP2/3 complex prefers to bind to these newly formed actin fi laments, which amplifi es the cofi lin-induced actin polymerization, resulting in protrusion formation.
(Invitrogen) at 1μg DNA per MatTek dish. After transfection, the cells were washed with fresh medium and incubated until use.
Immunofl uorescence
MTLn3 cells were fi xed and permeabilized as previously described . In brief, cells were simultaneously fi xed and extracted using 3.7% paraformaldehyde, 0.1% glutaraldehyde (Electron Microscopy Sciences), and 0.075% mg/ml saponin (Sigma-Aldrich) in PBS. Compared with sequential fi xation and detergent extraction protocols, simultaneous fi xation and extraction results in depletion of soluble G-actin . Primary antibodies diluted in blocking buffer were incubated with the fi xed cells for 1 h. Secondary antibodies (AlexaFluor 488 or 555; Molecular Probes) were diluted in blocking buffer and incubated with the cells for 1 h. Cells were washed and mounted in PBS.
FRET-based PIP 2 hydrolysis assay Kinetic analysis of PIP 2 hydrolysis by FRET was assayed as described (van der Wal et al., 2001 ) with some modifi cations. Cells were placed on an inverted microscope (model 470; Olympus) equipped with Zeiss EC PlanNeoFluar 40×/1.3 OIL PH3 objective, a computer-driven cooled CCD camera, humidifi ed CO 2 chamber, and were kept at 37°C. Excitation was done with a Lambda DG-4 using a D430/25 CFP excitation fi lter, and IPLab Spectrum software (VayTek) was used to collect images. A ND2 fi lter was used in the excitation path to minimize photo toxicity during long experiments. A dual-band dichroic mirror 86002v2bs was used (Chroma Technology Corp.), and emission was collected on a dual-view 505 dcxr D465/30m (CFP) HQ535/30m (YFP) (Optical Insights, LLC). Images were collected every 3 s and stored on the computer. Using a custom-made Visual Basic (vb6.0) program, the images were imported and analyzed. Following a threshold step, background regions were determined and the background was measured and subtracted from the images. Cells were traced with a fi xed threshold and the mean fl uorescence level of CFP and YFP of the whole cells was measured. CFP leak-through was subtracted from the YFP values (leak-through factor was 0.84 and was established in cells expressing only CFP) and the YFP value was multiplied by a fi xed factor which was determined at the onset of the experiment to achieve a YFP/CFP ratio of 1. FRET changes were measured as an offset of the initial value. For more details see Fig. S1 .
Antibody-based PIP 2 assay PIP 2 antibody was purchased from Assay Designs, Inc. Pictures were taken using 60× NA1.4 infi nity-corrected optics on a microscope (model IX170; Olympus) supplemented with a computer-driven cooled CCD camera. IPLab Spectrum software (VayTek) was used to collect images, and exposure times were kept constant. Digital images were linearly converted in NIH ImageJ and analyzed using a customized macro. The macro averages the fl uorescence intensity in 29 annuli, ranging from 1.1 μm outside the cell periphery and extending approximate 6 μm inside the cell (consecutive annuli are 0.22 μm apart from each other). The averaged fl uorescence intensity of the fi rst 1 μm inside the cell was used to represent the membrane PIP 2 changes. For every condition, at least 30 cells were analyzed.
Membrane fractionation
A 100-mm plate of MTLn3 cells at ‫%09ف‬ confl uence was lysed with 100 μl of ice-cold lysis buffer (50 mM Tris, pH 7.5, 300 mM NaCl, 5 mM EGTA, 20 mM DTT, 2% Triton X-100, 1× protease inhibitor mixture, and 50 mM NaF). Cell lysates were collected after incubating the lysates on ice for 30 min. The harvested cell lysate was mixed with 60% OptiPrep (AXIS-SHIELD PoC AS) to yield 40% OptiPrep fi nal. The lysate containing 40% OptiPrep was transferred to the bottom of a centrifuge tube. 1 ml 30% OptiPrep was added carefully on top of 40% OptiPrep lysate to avoid disrupting the interface. 300 μl of 5% OptiPrep was added carefully on top of 30% OptiPrep. Tubes were centrifuged for 12-14 h at 4°C in a rotor at 100,000 g (TLS55; Beckman Coulter). Gradient fractions (150 μl) were collected and cofi lin content was analyzed by immunoblotting. To analyze the amount of PIP 2 , 1 μl of each gradient fraction was dot blotted onto nitrocellulose and dried for 1 h. Dot blot was then probed with a monoclonal antibody raised against PI(4,5)P 2 (Assay Designs). Densitometry analysis was done in ImageJ (W.S. Rasband, NIH, Bethesda, MD; http://rsb.info .nih.gov/ij/). The amount of cofi lin or PIP 2 in the low-density fraction was normalized against the total amount of cofi lin in the lysate.
Cofi lin activity assay
The relative cofi lin-severing activity was quantifi ed using a slightly modifi ed version of the established microscopy severing assay (Chan et al., 2000; Ichetovkin et al., 2000) . In brief, MTLn3 cell lysates were prepared by lysing cells (3 × 10 7 cells/ml) in lysis buffer at different times after EGF stimulation. Rhodamine-and biotin-labeled F-actin were prepared by incubating 0.4 μM rhodamine-labeled actin, 0.2 μM biotin-labeled actin, and 1.4 μM unlabeled actin in polymerization buffer and 0.2 μM phalloidin for no more than 1.5 h at room temperature. A fl ow chamber precoated with 0.5% nitrocellulose in amylacetate was perfused in biotin antibody for 5 min. Rhodamine/biotin-labeled F-actin was diluted 30 times to perfuse in the fl ow chamber. The severing of actin fi laments by cell lysates prepared from MTLn3 cells was observed under a TIRF microscope. Due to the crosslinking of fi laments to the solid surface, the fi laments are stable indefi nitely, and 20 min was used routinely as the control check time to see if any fi lament severing occurred in the absence of cofi lin. Filament numbers were quantifi ed in ImageJ. The relative cofi lin activity was measured by dividing the number of fi laments 5-10 min after adding the lysates by the number of fi laments before adding cell lysates in the same fi eld. Confocal experiments using function-blocking cofi lin antibodies were done to confi rm that all severing activity was due to cofi lin.
Sensitized emission
Sensitized emission was calculated from confocal GFP and mCherry images using a highly corrected algorithm as recently described (van Rheenen et al., 2004) , in a custom-made Visual Basic program. In short, three images were collected with a confocal microscope (TCS SP2 AOBS; Leica) with 60× oil immersion optics at 25°C; a GFP image excited at 488 nm ( 488nm GFP), a mCherry image excited at 488 nm ( 488nm mCherry), and a mCherry image excited at 560 nm ( 560nm mCherry). Upon background subtraction, sensitized emission (FRET(sens)) was calculated as follows:
where α is the correction factor for mCherry fl uorescence excitation at 488 nm and detected in the 488nm GFP channel, β is the leakthrough of GFP in the 488nm mCherry channel, δ that for leak-through of sensitized emission back into the 488nm GFP channel, and γ relates mCherry fl uorescence detected in the 488nm GFP channel to the mCherry fl uorescence detected in the 488nm mCherry channel. The α, β, γ, and δ correction factors were determined on-line from cells expressing either GFP or mCherry fl uorescence proteins alone, present on the same coverslip (for more details see van Rheenen et al., 2004) . For each image, the correction factors were redetermined to correct for laser fl uctuations. Apparent FRET effi ciencies (E d and E a ) were obtained by relating FRET (sens) to the GFP or mCherry image, respectively. To compare independent measurements of E a , E a was divided by the γ factor (van Rheenen et al., 2004) . Regions of interest such as the PM were determined by a threshold step in the mCherry image. FRET values were calculated by applying the same algorithms on the raw mean data of the region of interest.
Acceptor photobleaching experiments
Donor and acceptor confocal images were collected before and after photobleaching of the acceptor. In a custom-made Visual Basic program, the post-bleached donor image was corrected for imaging-bleaching and the gain in donor and the loss in acceptor fl uorescence were determined at the cell periphery. FRET was calculated by relating the gain of donor fl uorescence to the total amount post-bleach acceptor fl uorescence. All FRET calculations were performed on the mean values of regions of interest of the periphery of the cell. No signifi cant photo conversion of the acceptor was observed during photobleaching.
Colocalization analysis
Colocalization analyses were performed on the fi rst 1 μm of a cell. Cells were precisely traced on phase-contrast images. Pixels along the perimeter were measured for intensity correlation. The perimeter was inset by one pixel and measured. This was repeated iteratively to provide Pearson's coeffi cient from the outer edge of the cell toward the center at 0.22-μm steps for the fi rst 1 μm of the cell. Pearson's correlation coeffi cients (r) were calculated as previously described where element X was a pixel value of one probe, and Y the corresponding pixel value of the other probe at the same spatial location, and N the number of pixels.
For scatterplot analyses, the fi rst 1 μm of the cell was precisely traced on the fl uorescent images and the analysis was performed in a custom-made Visual Basic program, where the pixel intensity of the fi rst image (image A) was plotted against the pixel intensity of the second image (image B). However, because of small misalignments in fi lter sets, the image of the second probe (image B) can have a pixel shift relative to the image of the fi rst probe (image A). Before analysis, images were corrected for these pixel shifts as follows: The spatial correlation for pixels in which the gray value in both image A and B is >0 were analyzed with the Pearson's correlation coeffi cient. Then, image B was moved one pixel to the left, and the correlation was recalculated. If a misalignment in fi lter resulted in a pixel shift to the right, image B that is moved one pixel to the left will have a higher spatial correlation with image A then the non-moved image B. If this was true, image B was moved permanently. The correlation was calculated for a move of image B to the left, right, up, or down. This procedure was repeated iteratively until the coeffi cient no longer increased. Figure S1 explains the PIP 2 FRET assay. Figure S2 shows the specifi city of PIP 2 antibodies used in this study. Figure S3 explains why the Pearson's correlation coeffi cient is insensitive to relative changes in images. Figure  S4 shows cofi lin membrane FRET controls. Figure S5 explains the loss of PIP 2 upon rapamycin addition. Video 1 shows the lamellipod increase upon rapamycin treatment. Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.200706206/DC1.
Online supplemental material
